Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Cash & Current Investments: 2018-2024

Historic Cash & Current Investments for Whitehawk Therapeutics (WHWK) over the last 7 years, with Dec 2024 value amounting to $47.2 million.

  • Whitehawk Therapeutics' Cash & Current Investments rose 358.75% to $287.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $775.0 million, marking a year-over-year increase of 129.09%. This contributed to the annual value of $47.2 million for FY2024, which is 56.60% down from last year.
  • According to the latest figures from FY2024, Whitehawk Therapeutics' Cash & Current Investments is $47.2 million, which was down 56.60% from $108.8 million recorded in FY2023.
  • Whitehawk Therapeutics' Cash & Current Investments' 5-year high stood at $172.6 million during FY2022, with a 5-year trough of $4.5 million in FY2020.
  • Its 3-year average for Cash & Current Investments is $109.5 million, with a median of $108.8 million in 2023.
  • As far as peak fluctuations go, Whitehawk Therapeutics' Cash & Current Investments slumped by 88.44% in 2020, and later surged by 3,244.31% in 2021.
  • Whitehawk Therapeutics' Cash & Current Investments (Yearly) stood at $4.5 million in 2020, then spiked by 3,244.31% to $149.0 million in 2021, then climbed by 15.82% to $172.6 million in 2022, then crashed by 36.92% to $108.8 million in 2023, then crashed by 56.60% to $47.2 million in 2024.